论文部分内容阅读
目的:观察邓氏冠心胶囊对冠心病患者PCI术后血脂及超敏-C反应蛋白的影响。方法:61例患者采取前瞻随机对照方法分为2组,治疗组31例,采用邓氏冠心胶囊结合西药治疗;对照组30例,采用单纯西药治疗。观察冠心病患者PCI术后血脂及超敏-C反应蛋白(Hs-CRP)的影响。结果:2组总胆固醇(TC)、甘油三脂(TG)、高密度脂蛋白胆固醇(HDL-C)、低密度脂蛋白胆固醇(LDL-C)、Hs-CRP在术后3月较术前均有明显降低,与治疗前比较,差异均有显著性意义(P<0.05);2组治疗后LDL-C比较,差异有显著性意义(P<0.05)。结论:邓氏冠心胶囊能不同程度地改善患者心功能、血脂代谢、Hs-CRP,尤其能明显降低患者的LDL-C。
Objective: To observe the effect of Deng’s Guanxin Capsule on blood lipids and high-sensitivity C-reactive protein in patients with coronary heart disease after PCI. Methods: Sixty-one patients were randomly divided into two groups according to the prospective randomized controlled trial. The treatment group consisted of 31 patients, treated with Deng’s Guanxin capsule combined with western medicine, and the control group with 30 patients treated with western medicine alone. To observe the influence of blood lipids and Hs-CRP in patients with coronary heart disease after PCI. Results: The total cholesterol (TC), triglyceride (TG), high density lipoprotein cholesterol (HDL-C), low density lipoprotein cholesterol (LDL-C) and Hs- (P <0.05). There was significant difference in LDL-C between the two groups after treatment (P <0.05). Conclusion: Dengs Guanxin Capsule can improve cardiac function, lipid metabolism, Hs-CRP in patients with varying degrees of severity, especially in patients with LDL-C.